Literature DB >> 34150595

Prognostic Significance of Vocal Cord Mobility after Laryngeal Preservation Protocols in Locally Advanced Laryngopharyngeal Cancers: A Retrospective Analysis.

Vishal U S Rao1, Kinjal Shankar Majumdar1,2, Anand Subash1, Nabanita Banerjee3, Piyush Sinha1,4, Rachana Prasad1,5, Akshay Kudpaje1, Ravi C Nayar1.   

Abstract

In the present study, we look at the prognostic implications of the recovery of vocal cord mobility after treatment in T3 laryngeal and hypopharyngeal cancers with fixed vocal cords. Patients with T3 laryngeal and hypopharyngeal carcinoma were considered for the study. All patients were treated with standard laryngeal preservation protocols as per treatment guidelines. Recovery of vocal cord functions was assessed with serial flexible laryngoscopic evaluation. Recovery of vocal cord mobility was compared with oncological outcomes. Twenty seven patients were available for final analysis. Cases, where vocal cords remained fixed or continued to have restricted mobility on follow up, were categorised as "unfavourable" and those with complete recovery of function as compared to pre treatment FOL as "Favourable". Thirteen (48%) patients did not regain complete mobility of vocal cords. Six patients from the 'unfavourable' group (46%) developed recurrence, whereas only one patient from the 'favourable' group (7%) had a recurrence (p = 0.03). The findings of the present study suggest that failure to regain complete vocal cord mobility after CTRT is a poor prognostic factor in T3 laryngeal and hypopharyngeal cancers. © Association of Otolaryngologists of India 2021.

Entities:  

Keywords:  Chemoradiotherapy; Functional larynx; Laryngeal cancer; Organ preservation; Vocal cord

Year:  2021        PMID: 34150595      PMCID: PMC8163924          DOI: 10.1007/s12070-020-02306-w

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  15 in total

1.  Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States.

Authors:  Patti A Groome; Brian O'Sullivan; Jonathan C Irish; Deanna M Rothwell; Karleen Schulze; Padraig R Warde; Ken M Schneider; Robert G Mackenzie; D Ian Hodson; J Alex Hammond; Sunil P P Gulavita; Libni J Eapen; Peter F Dixon; Randy J Bissett; William J Mackillop
Journal:  J Clin Oncol       Date:  2003-02-01       Impact factor: 44.544

2.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

3.  [On the mechanism of hemilaryngeal fixation in pyriform sinus carcinoma and its clinical significance].

Authors:  W Liu; S Fei; S Li
Journal:  Zhonghua Er Bi Yan Hou Ke Za Zhi       Date:  1997-06

4.  Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck.

Authors:  D J Adelstein; P Lavertu; J P Saxton; M Secic; B G Wood; J R Wanamaker; I Eliachar; M Strome; M A Larto
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

5.  Outcomes of elective total laryngectomy for laryngopharyngeal dysfunction in disease-free head and neck cancer survivors.

Authors:  Katherine A Hutcheson; Clare P Alvarez; Denise A Barringer; Michael E Kupferman; Peter R Lapine; Jan S Lewin
Journal:  Otolaryngol Head Neck Surg       Date:  2012-01-10       Impact factor: 3.497

6.  Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891.

Authors:  J-L Lefebvre; G Andry; D Chevalier; B Luboinski; L Collette; L Traissac; D de Raucourt; J A Langendijk
Journal:  Ann Oncol       Date:  2012-04-06       Impact factor: 32.976

7.  Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.

Authors:  Jean-Louis Lefebvre; K Kian Ang
Journal:  Head Neck       Date:  2009-04       Impact factor: 3.147

8.  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.

Authors:  Mitchell Machtay; Jennifer Moughan; Andrew Trotti; Adam S Garden; Randal S Weber; Jay S Cooper; Arlene Forastiere; K Kian Ang
Journal:  J Clin Oncol       Date:  2008-06-16       Impact factor: 44.544

9.  Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.

Authors:  Arlene A Forastiere; Qiang Zhang; Randal S Weber; Moshe H Maor; Helmuth Goepfert; Thomas F Pajak; William Morrison; Bonnie Glisson; Andy Trotti; John A Ridge; Wade Thorstad; Henry Wagner; John F Ensley; Jay S Cooper
Journal:  J Clin Oncol       Date:  2012-11-26       Impact factor: 44.544

10.  Epidemiological review of laryngeal cancer: An Indian perspective.

Authors:  Saurabh Bobdey; Aanchal Jain; Ganesh Balasubramanium
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.